REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -22.7% | 1,400 | -33.1% | 0.00% | – |
| Q2 2023 | $22,000 | +266.7% | 2,093 | +230.6% | 0.00% | – |
| Q1 2023 | $6,000 | -40.0% | 633 | -7.2% | 0.00% | – |
| Q4 2022 | $10,000 | +25.0% | 682 | +9.1% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 625 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 625 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 625 | -30.8% | 0.00% | – |
| Q4 2021 | $20,000 | -42.9% | 903 | -32.0% | 0.00% | – |
| Q3 2021 | $35,000 | -12.5% | 1,328 | +4.7% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 1,268 | -6.5% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 1,356 | +86.0% | 0.00% | – |
| Q4 2020 | $25,000 | +316.7% | 729 | +264.5% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |